Nanostructure Surface Coated Medical Implants and Methods of Using the Same

Patent metadata

Field	Value
Publication number	US-2018185549-A1
Application number	US-201715722897-A
Country	US
Kind code	A1
Filing date	Oct 2, 2017
Priority date	Mar 16, 2007
Publication date	Jul 5, 2018
Grant date	—

Abstract

Compositions including a surface or film comprising nanofibers, nanotubes or microwells comprising a bioactive agent for elution to the surrounding tissue upon placement of the composition in a subject are disclosed. The compositions are useful in medical implants and methods of treating a patient in need of an implant, including orthopedic implants, dental implants, cardiovascular implants, neurological implants, neurovascular implants, gastrointestinal implants, muscular implants, and ocular implants.

First claim

1 - 106 . (canceled)

107 . A method comprising administering to a subject a composition that comprises a surface or film comprising a vertically oriented array of a plurality of nanotubes or microwells,
wherein a bioactive agent is filled into the nanotubes or microwells themselves, wherein a first end of the array of the plurality of filled nanotubes or microwells is in contact with the surface or film, and wherein the plurality of nanotubes or microwells is capped with a polymeric erodible capping film to provide for delayed elution of the bioactive agent from within the nanotubes or microwells to the surrounding tissue upon placement in a subject and erosion of the capping film.

108 . The method of claim 107 , wherein the subject is a human.

109 . The method of claim 107 , wherein the subject is a laboratory, agricultural, domestic or wild animal.

110 . The method of claim 107 , wherein the composition is an orthopedic implant, a dental implant, a cardiovascular implant, a neurological implant, a neurovascular implant, a gastrointestinal implant, a muscular implant, or an ocular implant.

111 . The method of claim 110 , wherein the composition is configured for enhancing osseointegration of the orthopedic implant.

112 . The method of claim 107 , wherein the composition is a patch for localized delivery of said bioactive agent to a soft tissue.

113 . The method of claim 107 , wherein said surface or film unfurls in the presence of a hydrating liquid.

114 . The method of claim 107 , wherein said surface or film further comprises a covalently attached bioactive agent.

115 . The method of claim 107 , wherein said surface or film is comprised of poly(DL-lactide-co-glycolide) (PLGA), poly(DL-lactide-co-ϵ-caprolactone) (DLPLCL), poly(ϵ-caprolactone) (PCL), gelatin, agarose, poly(methyl methacrylate), galatin/ϵ-caprolactone, collagen-GAG, collagen, fibrin, PLA, PGA, PLA-PGA co-polymers, poly(anhydrides), poly(hydroxy acids), poly(ortho esters), poly(propylfumerates), poly(caprolactones), poly(hydroxyvalerate), polyamides, polyamino acids, polyacetals, biodegradable polycyanoacrylates, biodegradable polyurethanes and polysaccharides, polypyrrole, polyanilines, polythiophene, polystyrene, polyesters, non-biodegradable polyurethanes, polyureas, poly(ethylene vinyl acetate), polypropylene, polymethacrylate, polyethylene, polycarbonates, poly(ethylene oxide), co-polymers of the above, mixtures of the above, and adducts of the above, or combinations thereof.

116 . The method of claim 107 , wherein said nanotubes range in length from about 1 μm to about 500 μm.

117 . The method of claim 107 , wherein said nanotubes range in diameter from about 3 nm to about 300 nm.

118 . The method of claim 117 , wherein said surface or film comprises nanotubes at a density greater than 10,000,000 nanotubes per square centimeter.

119 . The method of claim 118 , wherein said surface or film comprises nanotubes at a density greater than 25,000,000 nanotubes per square centimeter, wherein said density provides for an extracellular matrix compatible tissue adhesive.

120 . The method of claim 107 , wherein said nanotubes have a pore diameter range from about 3 nm to about 250 nm.

121 . The method of claim 107 , wherein said surface or film ranges in thickness from about 1 μm to about 2.5 mm.

122 . The method of claim 107 , wherein said microwells range in diameter from about 1 μm to about 150 μm.

123 . The method of claim 122 , wherein said surface or film comprises microwells at a density greater than 150,000 microwells per square centimeter.

124 . The method of claim 107 , wherein said nanotubes or microwells further comprise an agent to facilitate cell adhesion and cell growth selected from the group consisting of laminin, fibrin, fibronectin, proteoglycans, glycoproteins, glycosaminoglycans, chemotactic agents, and growth factors.

125 . The method of claim 107 , wherein said bioactive agent is selected from a polypeptide, growth factor, a steroid agent, an antibody therapy, an antibody fragment, a DNA, an RNA, and siRNA, an antimicrobial agent, an antibiotic, an antiretroviral drug, an anti-inflammatory compound, an antitumor agent, anti-angiogeneic agent, and a chemotherapeutic agent.

126 . The method of claim 107 , wherein said surface or film further comprises cells.

127 . The method of claim 126 , wherein said cell is a stem cell, a retinal progenitor cell, a cardiac progenitor cell, an osteoprogenitor cell, or a neuronal progenitor cell.

Assignees

• Univ California
• Penn State Res Found

Inventors

• Desai Tejal A
• Popat Ketul C
• Grimes Craig A

Classifications

• A61F2310/0097

  Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics · CPC title

• A61F2/0077

  Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title

• A61F2310/00616

  Coating made of titanium oxide or hydroxides · CPC title

• A61L2300/414

  Growth factors · CPC title

• A61F2310/00437

  Coating made of silicon or Si-based alloys · CPC title